Pfizer is weighing up retaining Consumer
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Pfizer is weighing up retaining its Consumer Healthcare business with the firm struggling to find a buyer for the unit at a price it deems acceptable.